Q/C Technologies, Inc. Accounts Receivable, Related Parties
Q/C Technologies, Inc. (QCLS) had Accounts Receivable, Related Parties of $470.00 thousand as of 2017-12-31, per its 10-K/A filed 2018-07-13.
Discontinued › Notes › Receivables
us-gaap:AccountsReceivableRelatedParties · last filed 2018-07-13
- 2017-12-31: Accounts Receivable, Related Parties $470.00K; Accounts Receivable, Related Parties as first filed $570.80K.
| Period end | Accounts Receivable, Related Parties | Accounts Receivable, Related Parties as first filed |
|---|---|---|
| 2017-12-31 | $470.00K 10-K/A · filed 2018-07-13 | $570.80K 10-K · filed 2018-04-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |